Jeetinder Singh Mahal - 24 Sep 2021 Form 3 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Officer
Signature
By: /s/ Jeet Mahal
Issuer symbol
JSPR
Transactions as of
24 Sep 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 16:09:48 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JSPR Voting Common Stock 109,627 24 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JSPR Stock Option (right to buy) 24 Sep 2021 Common Stock 182,713 $0.7100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

Title: Chief Financial Officer, Chief Business Officer and Corporate Secretary; Exhibit 24 - Power of Attorney